New CDC Flu Vaccine Recommendation for Adults 65+
Returning guest, Dr. Gregg Sylvester, Chief Health Officer at CSL Seqirus, one of the world’s largest influenza providers, discusses the CDC’s Advisory Committee on Immunization Practices (ACIP) vote around preferred flu vaccines for adults 65+. The vote included CSL Seqirus’ FLUAD ® Quadrivalent as a preferentially recommended seasonal influenza vaccine based on the clinical benefits compared to standard egg-based influenza vaccines. He talks about the implications of this recommendation and how it may translate into improved outcomes for adults 65+, as well as lessen the burden on healthcare systems, expectations for the 2022/23 flu season, choosing a vaccine, and best practices.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Vaccine. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Vaccine and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Vaccine?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Dr. Gregg Sylvester has led Seqirus Medical Affairs since 2016, overseeing the global team that scientifically differentiates our vaccines by generating Real World Evidence and presenting Seqirus research to national vaccine recommending organizations. Gregg has extensive experience in the pharmaceutical industry, government and patient care. Prior to joining Seqirus, he led Medical Affairs teams in the worldwide launches of Gardasil, Prevnar 13 and Trumenba. Gregg obtained specialty boards in Pediatrics and General Preventive Medicine. Augmenting his clinical expertise, he served in the CDC Epidemic Intelligence Service and as a Public Policy Fellow in the U.S. Congress. During his distinguished career in state government, Gregg was appointed to the Cabinet Secretary for Health and Social Services in Delaware, leading the state’s largest agency. Gregg has an MD from Albany Medical College and an MPH from the Johns Hopkins Bloomberg School of Public Health.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
